Efficient sequence specific gene silencing of myeloid cell leukemia sequence 1 is possible through the use of siRNA technology. By selecting particular siRNAs directed to myeloid cell leukemia sequence 1 by rationale design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes.

 
Web www.patentalert.com

< siRNA targeting interleukin-1 receptor-associated kinase 4 (IRAK4)

> Non-nucleotide composition and method for inhibiting platelet aggregation

> Synthesis of selenium-derivatized nucleosides, nucleotides, phosphoramidites, triphosphates and nucleic acids
~ 00544